CVS Health Corp.’s drug benefits unit is trying to entice health insurance plans to cover Wegovy, Novo Nordisk A/S’s pricey weight-loss shot, for more patients by allowing them to charge copays as high as $200.
It’s the latest move by pharmacy benefit managers, which negotiate drug prices on behalf of health plans, to deal with the surging demand for weight-loss medicines. The copay option would take effect starting next year.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.